A Single and Multiple Ascending Dose Study of JNJ-64457744

Clinical trial NCT05423106 · TERMINATED

Trial details

NCT number: NCT05423106
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatitis B, Chronic

Start date: 2022-07-04
Primary completion: 2023-03-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.